Discriminative stimulus effects of tramadol in humans

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 1, 2011, Pages 255-262

  Duke, Angela N ^a   Bigelow, George E ^a   Lanier, Ryan K ^a,b   Strain, Eric C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rock Creek Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; METHYLPHENIDATE; PLACEBO; TRAMADOL;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG DOSE COMPARISON; DRUG EFFECT; HUMAN; INSTRUMENTAL CONDITIONING; MALE; MULTIPLE CHOICE TEST; OPIATE ADDICTION; PRIORITY JOURNAL; REINFORCEMENT; VISUAL ANALOG SCALE; VOLUNTEER;

ADULT; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOUBLE-BLIND METHOD; HUMANS; MALE; REINFORCEMENT SCHEDULE; TRAMADOL;

EID: 79959513989     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.181131     Document Type: Article

References (37)

1. Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, and Woody GE (2006) A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 31:465-476. (Pubitemid 43744403)
2. Bickel WK, Bigelow GE, Preston KL, and Liebson IA (1989) Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect. J Pharmacol Exp Ther 251:1053-1063. (Pubitemid 20024924)
3. Cami J, Lama X, and Farre M (1994) Acute effects of tramadol in methadonemaintained volunteers. Drugs 47 (Suppl 1):39-43. (Pubitemid 24132195)
4. Carroll CP, Walsh SL, Bigelow GE, Strain EC, and Preston KL (2006) Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol 14:109-120. (Pubitemid 43988629)
5. Cicero TJ, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, Senay EC, and Woody GE (1999) A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 57:7-22. (Pubitemid 29452951)
6. Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, and Muñoz A (2005) Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf 14:851-859. (Pubitemid 43056111)
7. Desmeules JA, Piguet V, Collart L, and Dayer P (1996) Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 41:7-12. (Pubitemid 26009905)
8. Dykstra LA, Preston KL, and Bigelow GE (1997) Discriminative stimulus and subjective effects of opioids with μ and κ activity: data from laboratory animals and human subjects. Psychopharmacology 130:14-27. (Pubitemid 27107781)
9. Epstein DH, Preston KL, and Jasinski DR (2006) Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol 73:90-99.
10. Fliegert F, Kurth B, and Göhler K (2005) The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Eur J Clin Pharmacol 61:257-266. (Pubitemid 40884019)
11. Filip M, Wydra K, Inan SY, Dziedzicka-Wasylewska M, and Przegaliński E (2004) Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats. Eur J Pharmacol 498:143-151. (Pubitemid 39208073)
12. Gillen C, Haurand M, Kobelt DJ, and Wnendt S (2000) Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor. Naunyn- Schmiedebergs Arch Pharmacol 362:116-121. (Pubitemid 30640039)
13. Grond S and Sablotzki A (2004) Clinical pharmacology of tramadol. Clin Pharmacokinet 43:879-923. (Pubitemid 39447033)
14. Hennies HH, Friderichs E, and Schneider J (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38:877-880.
15. Herling S and Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571-1584. (Pubitemid 11075644)
16. Ide S, Minami M, Ishihara K, Uhl GR, Sora I, and Ikeda K (2006) Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 51:651-658. (Pubitemid 44215970)
17. Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, and Woody GE (2006) The diversion of Ultram, Ultracet, and generic tramadol HCL. J Addict Dis 25:53-58. (Pubitemid 44157069)
18. Jones HE, Bigelow GE, and Preston KL (1999) Assessment of opioid partial agonist activity with a three-choice hydromoprhone dose-discrimination procedure. J Pharmacol Exp Ther 289:1350-1361. (Pubitemid 29246664)
19. Kamien JB, Bickel WK, Hughes JR, Higgins ST, and Smith BJ (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology 111:259-270. (Pubitemid 23165254)
20. Kelly TH, Stoops WW, Perry AS, Prendergast MA, and Rush CR (2003) Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev 2:227-260.
21. Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, and Strain EC (2010) Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology 211:457-466.
22. Lofwall MR, Walsh SL, Bigelow GE, and Strain EC (2007) Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology 194:381-393. (Pubitemid 47389347)
23. O'Connor EC and Mead AN (2010) Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacol Biochem Behav 96:279-286.
24. Preston KL and Bigelow GE (2000) Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination. J Pharmacol Exp Ther 295:114-124.
25. Preston KL, Bigelow GE, Bickel W, and Liebson IA (1987) Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. J Pharmacol Exp Ther 243:1002-1009. (Pubitemid 18017153)
26. Preston KL, Jasinski DR, and Testa M (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 27:7-17.
27. Raffa RB (2008) Basic pharmacology relevant to drug abuse assessment: tramadol as example. J Clin Pharm Ther 33:101-108.
28. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, and Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260:275-285.
29. Ren YH and Zheng JW (2000) Influence of tramadol on morphine discriminative behavior in rats. Acta Pharmacol Sin 21:924-926.
30. Sevak RJ, Stoops WW, Hays LR, and Rush CR (2009) Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther 328:1007-1018.
31. Stoops WW, Lile JA, Glaser PE, and Rush CR (2005) Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate- trained humans. Exp Clin Psychopharmacol 13:56-64. (Pubitemid 40261830)
32. Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, and Yu J (2003) Tramadol versus buprenorphine for the treatment of opioid withdrawal: a rretrospective cohort control study. J Addict Dis 22:5-12. (Pubitemid 38174752)
33. Threlkeld M, Parran TV, Adelman CA, Grey SF, and Yu J (2006) Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. Am J Addict 15:186-191.
34. Woody GE, Senay EC, Geller A, Adams EH, Inciardi JA, Schnoll S, Muñoz A, and Cicero TJ (2003) An independent assessment of MEDWatch reporting for abuse/ dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend 72:163-168. (Pubitemid 37434008)
35. Yanagita T (1978) Drug dependence potential of 1-(m-methoxyphenyl)-2- dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys. Arzneimittelforschung 28:158-163.
36. Young AM, Stephens KR, Hein DW, and Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther 229:118-126. (Pubitemid 14082920)
37. Zacny JP (2005) Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug Alcohol Depend 80:273-278.